Author(s): Gasbarrini A, Gasbarrini G, Pelosini I, Scarpignato C Affiliation(s): Department of Internal Medicine, Gemelli University Hospital, Catholic University of Sacred Heart, Rome, Italy. [email protected] Publication date & source: 2006, Digestion. , 73 Suppl 1:129-35.
Epub 2006 Feb 8. Publication type: Review Rifaximin is a non-absorbed semisynthetic rifamycin derivative with a broad spectrum of antibacterial activity including Gram-positive and Gram-negative bacteria, both aerobes and anaerobes. Although originally developed for the treatment of infectious diarrhea, the appreciation of the pathogenic role of gut bacteria in several organic and functional gastrointestinal diseases has increasingly broadened its clinical use.
Being the antibiotic active against Helicobacter pylori, even towards clarithromycin-resistant strain, and being the primary resistance very rare, several investigations explored its potential use for eradication of the microorganism. Rifaximin ... more.
I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.